Navigation Links
Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
Date:5/28/2008

ProLindac Demonstrates Sustained and Significant Reductions in Cancer

Market CA-125

DALLAS, May 28 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that the company gave an invited oral presentation on its lead anticancer compound, ProLindac(TM) at the International Symposium on Polymer Therapeutics: Laboratory to Clinical Practice, taking place from May 26-28 in Valencia, Spain. The presentation was entitled "Promising Safety and Efficacy Results from an Ongoing Clinical Study of ProLindac in Recurrent Ovarian Cancer." ProLindac is Access' novel DACH platinum-polymer prodrug, which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials.

The invited presentation was given by Professor Esteban Cvitkovic, M.D., Access Pharmaceuticals' Senior Director, Clinical Oncology R&D. Professor Cvitkovic presented data from the ongoing Phase 2 monotherapy clinical study of ProLindac in patients with recurrent ovarian cancer. In two dosing regimens, ProLindac was given once every two weeks and once every three weeks. During the last and highest dose levels explored, sustained and significant reductions in the specific serum market Ca-125 were seen over multiple dosings in several patients. ProLindac was well-tolerated with minimal side-effects.

"We continue to be impressed by clinical results that indicate a significant DACH platinum drug effect with a very benign side effect profile," stated Jeffrey B. Davis, Access' President & CEO. "The sustained efficacy and minimal toxicity seen over multiple dosings provides further evidence that ProLindac has the potential to become a very important anticancer agent in the future. We are finalizing our plans for Phase 2 combination trials where we intend to look at multiple solid tumor types with ProLindac in combination with other cancer agents, like taxol and gemcitabine."


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
2. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
3. Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing
4. IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study
5. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
6. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
7. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
8. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
9. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
10. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
11. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...critical enzyme,s regulation may hold key to under... , , MEMPHIS, Tenn., Nov. 19 /PRNewswire-US...search Hospital have gained new insights into regu...ed calpains. , , As the cell,s molecular o...rocesses, including the movement of cells in tissu...
(Date:11/18/2008)... NeuroDiscovery Ltd (ASX:,NDL), a specialty neuro...any,and Sosei Group Corporation ("Sosei"; TSE Mo...armaceutical company, today announce that NeuroSol... efficacy data for NSL-043/SD118.,This investigat...pain and has,successfully completed Phase I clini...
(Date:11/18/2008)...luenza survey underscores that mothers need to get...Gold Medalist Kristi Yamaguchi joins initiative ,...e 78 percent of mothers in the United States consi...ening disease that can strike anyone, only half sa...this season, according to a new survey from the Am...
(Date:11/13/2008)... Risk of Heart Attacks, Deaths, RESTON, Va., Nov....ase,is the leading cause of death among Americans,...s of dollars and causing untold suffering. Now,the... even among those who,weren,t thought to be at ris... could cut their risk of a,heart attack, stroke an...
Breaking Medicine Technology:New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Seniors Can Be Heartened by New Study on Statins 2Human Urine Safe Productive Fertilizer 3130 1Human Urine Safe Productive Fertilizer 3130 2Human Urine Safe Productive Fertilizer 3130 3The Physical Therapy Profession Remains in High Demand 3127 1The Physical Therapy Profession Remains in High Demand 3127 2The Physical Therapy Profession Remains in High Demand 3127 3Webcast Alert 3A Expert Group Urges Businesses to Get Real About Weight Loss 3124 1Webcast Alert 3A Expert Group Urges Businesses to Get Real About Weight Loss 3124 2Biotech Hall of Fame Inductees Announced 1128 1Biotech Hall of Fame Inductees Announced 1128 2Biotech Hall of Fame Inductees Announced 1128 3Biotech Hall of Fame Inductees Announced 1128 4Biotech Hall of Fame Inductees Announced 1128 5Biotech Hall of Fame Inductees Announced 1128 6
(Date:11/21/2008)...Kids, parents and schools need to work together to...FRIDAY, Nov. 21 (HealthDay News) -- Behavior that ...ognized as bullying. , And as mounting research...the victim, mental-health professionals, schools, ...h new ways to combat this threatening behavior. ,...
(Date:11/21/2008)..., TALLAHASSEE, Fla. -- A Florida State Universit...g Wang has discovered an important new layer of re...ead to a greater understanding of the way cancer b...cal sciences at the College of Medicine, said the ...ose cancer and could lead to the design of new dru...
(Date:11/21/2008)...HARRISBURG, Pa., Nov. 21 /PRNewswire-USNewswire/ -...a, Governor Edward G. Rendell today remembered Li...ong teacher, an important partner in public servic...ylvania. , , "As the first woman elected li...ed public servant," said Governor Rendell. "Her fa...
(Date:11/21/2008)...TUCSON, Ariz., Nov. 21 T... ) today announced that Craig A. Norris, the Compa...to the Company,s Board of,Directors. Mr. Norris,...008,resignation of Steven I. Geringer and returns...erve on any committee of the Board. , Mr. N...
Breaking Medicine News(10 mins):Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3
...an physician who addressed a Southern African Deve... was one of the key factors that was at the centre...do.com) says, "Aids is neither an infectious disea...utritional syndrome caused by the alarming worldwi...
...tration has approved GlaxoSmithKline's new drug La...hose partial seizures are inadequately controlled ...an expansion of the //already-approved indications...es, and for the generalized seizures of Lennox-Gas...
...esearch Centre in India has shown that nearly 80 p...had considerable improvement when they followed sa...as conducted// as a result of doctors discovering ...ed neuropathy and often had to undergo amputation ...
...that has been plaguing mankind is the secret of ha...een able to unravel the mystery with a simple equa...ter a study of more than 1000 people. It is based ...red on a scale of 1 to 10 and the score is out of ...
Other Medicine News:Health News:The Happiness Formula.... 2
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: